Mohammad Fereidouni1, Hadis Rezapour2,3, Mansoore Saharkhiz2,3, Sara Mahmoudzadeh2,3, Malaksima Ayadilord2,3, Masoumeh Askari2,4, Samira Karbasi1,2, Arefeh Abbaszadeh5, Zahra Sadat Hoseini6, Gordon A Ferns7, Afsane Bahrami8. 1. Cellular and Molecular Research Center, Birjand University of Medical Sciences, Birjand, Iran. 2. Student Research Committee, Birjand University of Medical Sciences, Birjand, Iran. 3. Department of Immunology, Faculty of Medicine, Birjand University of Medical Sciences, Birjand, Iran. 4. Department of Anatomical Sciences, Faculty of Medicine, Birjand University of Medical Sciences, Birjand, Iran. 5. Cardiovascular Diseases Research Center, School of Medicine, Birjand University of Medical Sciences, Birjand, Iran. 6. Department of Psychology, University of Birjand, Birjand, Iran. 7. Division of Medical Education, Brighton and Sussex Medical School, Falmer, Brighton, BN1 9PH, Sussex, UK. 8. Cellular and Molecular Research Center, Birjand University of Medical Sciences, Birjand, Iran. afsaneb1369@gmail.com.
Abstract
BACKGROUND: Allergic disorders may have a bidirectional causal relationship with mental disorders. In this cross-sectional study, we aimed to assess the associations between cognitive abilities and emotional function tests and quality of life with the presence of allergic disease in young women. METHODS: A diagnosis of allergic disorders, comprising allergic rhinitis (AR), asthma and atopic dermatitis (AD), was confirmed by a specialist in allergy. The presence and severity of depression, anxiety, stress, insomnia and sleepiness were evaluated using validated questionnaires. Cognitive abilities and quality of life were assessed using standard instruments. RESULTS: Among 181 female young participants, the prevalence of AR, asthma and AD were 26.5%, 2.8%, and 14.9% respectively. The AR group had higher scores than the non-AR group for depression, anxiety, insomnia, and lower scores for physical and mental health-related quality of life. Moreover, the AD cases had higher scores on the depression and stress scale compared to those without it (p < 0.05). Asthmatic patients also had significantly higher insomnia severity and lower physical health-related quality of life than non-asthmatic. CONCLUSION: There was a high prevalence of psychological/psychiatric disorders that included: anxiety, and sleep problems among allergic women, and a reduced quality of life that may be associated with it.
BACKGROUND:Allergic disorders may have a bidirectional causal relationship with mental disorders. In this cross-sectional study, we aimed to assess the associations between cognitive abilities and emotional function tests and quality of life with the presence of allergic disease in young women. METHODS: A diagnosis of allergic disorders, comprising allergic rhinitis (AR), asthma and atopic dermatitis (AD), was confirmed by a specialist in allergy. The presence and severity of depression, anxiety, stress, insomnia and sleepiness were evaluated using validated questionnaires. Cognitive abilities and quality of life were assessed using standard instruments. RESULTS: Among 181 female young participants, the prevalence of AR, asthma and AD were 26.5%, 2.8%, and 14.9% respectively. The AR group had higher scores than the non-AR group for depression, anxiety, insomnia, and lower scores for physical and mental health-related quality of life. Moreover, the AD cases had higher scores on the depression and stress scale compared to those without it (p < 0.05). Asthmatic patients also had significantly higher insomnia severity and lower physical health-related quality of life than non-asthmatic. CONCLUSION: There was a high prevalence of psychological/psychiatric disorders that included: anxiety, and sleep problems among allergicwomen, and a reduced quality of life that may be associated with it.
Entities:
Keywords:
Anxiety; Asthma; Depression; Insomnia; Quality of life
Authors: Louis-Philippe Boulet; J Mark FitzGerald; Mark L Levy; Alvaro A Cruz; Soren Pedersen; Tari Haahtela; Eric D Bateman Journal: Eur Respir J Date: 2012-01-26 Impact factor: 16.671
Authors: Mark S Dykewicz; Dana V Wallace; Fuad Baroody; Jonathan Bernstein; Tim Craig; Ira Finegold; Faith Huang; Desiree Larenas-Linnemann; Eli Meltzer; Gary Steven; David I Bernstein; Joann Blessing-Moore; Chitra Dinakar; Matthew Greenhawt; Caroline C Horner; David A Khan; David Lang; John Oppenheimer; Jay M Portnoy; Christopher R Randolph; Matthew A Rank; Mark S Dykewicz; Dana V Wallace Journal: Ann Allergy Asthma Immunol Date: 2017-11-02 Impact factor: 6.347
Authors: Kim L Lavoie; André Cartier; Manon Labrecque; Simon L Bacon; Catherine Lemière; Jean-Luc Malo; Guillaume Lacoste; Silvana Barone; Pierre Verrier; Blaine Ditto Journal: Respir Med Date: 2005-04-15 Impact factor: 3.415
Authors: Jonathan M Feldman; Mahmood I Siddique; Enid Morales; Beverly Kaminski; Shou-En Lu; Paul M Lehrer Journal: Psychosom Med Date: 2005 Nov-Dec Impact factor: 4.312
Authors: L Antonicelli; C Bucca; M Neri; F De Benedetto; P Sabbatani; F Bonifazi; H G Eichler; Q Zhang; D D Yin Journal: Eur Respir J Date: 2004-05 Impact factor: 16.671